ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that the bid
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ProPhase Labs’s 8K filing here. About ProPhase Labs (Get Free Report) ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: […]
More Stories
ProAssurance (NYSE:PRA) Upgraded at StockNews.com
StockNews.com upgraded shares of ProAssurance (NYSE:PRA – Free Report) from a hold rating to a buy rating in a research...
Martin Midstream Partners (NASDAQ:MMLP) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Martin Midstream Partners (NASDAQ:MMLP – Free Report) in a research report released on Thursday...
StockNews.com Begins Coverage on Citizens (NASDAQ:CIZN)
Research analysts at StockNews.com started coverage on shares of Citizens (NASDAQ:CIZN – Get Free Report) in a report released on...
Zapp Electric Vehicles Group Limited (NASDAQ:ZAPPW) Short Interest Down 39.5% in December
Zapp Electric Vehicles Group Limited (NASDAQ:ZAPPW – Get Free Report) saw a significant drop in short interest in December. As...
Turning Point Brands (NYSE:TPB) Cut to Hold at StockNews.com
StockNews.com lowered shares of Turning Point Brands (NYSE:TPB – Free Report) from a buy rating to a hold rating in...
Progressive (NYSE:PGR) Upgraded at Raymond James
Raymond James upgraded shares of Progressive (NYSE:PGR – Free Report) from a market perform rating to an outperform rating in...